Amylyx Pharmaceuticals, Inc. Earnings Per Share Diluted

Quick Answer

Amylyx Pharmaceuticals, Inc. reported Earnings Per Share Diluted of $1.53 (loss) per share for the year ending 2025.

  • Amylyx Pharmaceuticals, Inc. showed an increase of +65.5% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from Amylyx Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
  • XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s Earnings Per Share Diluted has grown by 88.5%.
  • Historical annual values: Fiscal year 2025: $1.53 (loss) per share | Fiscal year 2024: $4.43 (loss) per share | Fiscal year 2023: $0.70 per share | Fiscal year 2022: $3.39 (loss) per share | Fiscal year 2021: $13.35 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: